MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Biolargo Inc (OP:BLGO)

0.1348 -0.0052 (-3.71%)
Streaming Delayed Price Updated: 3:58 PM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 680,742
Open 0.1356
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1400
Today's Range 0.1300 - 0.1399
52wk Range 0.1270 - 0.2576
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
BioLargo Subsidiary Clyra Medical Signs Exclusive Distribution Agreement with Al- Hikma FZCO for ViaCLYR(TM) Across the Middle East, North Africa, and Adjacent Markets
Via ACCESS Newswire
News headline image
BioLargo Signs Memorandum of Understanding with Aquatech to Accelerate Commercialization of PFAS Treatment Technology
Via ACCESS Newswire

Performance

YTD
-28.2%
-28.2%
1 Month
-6.4%
-6.4%
3 Month
-22.9%
-22.9%
6 Month
-20.4%
-20.4%
1 Year
-46.0%
-46.0%

More News

Read More
News headline image
BioLargo to Participate in a Town Hall Meeting Hosted by the BioLargo Shareholder Community on Discord on May 5, 2026
Via ACCESS Newswire
News headline image
BioLargo Engineering, Science & Technologies Awarded $1.2 Million Contract to Design Pilot-Scale Minerals Processing Facility for Resource Recovery
Via ACCESS Newswire
News headline image
BioLargo CEO Dennis Calvert to Present Global Environmental Leadership Award to Robert Bilott at Nassau County PFAS Forum
Via ACCESS Newswire
News headline image
BioLargo Reports Annual 2025 Operating and Financial Results
Via ACCESS Newswire
News headline image
BioLargo Q4 2025 and Year End Earnings Results Webcast and Conference Call on Thursday, March 5th, 2026 - 12:00 PM Eastern Time
Via ACCESS Newswire
News headline image
BioLargo Subsidiary Clyra Medical Highlights Key Opinion Leader Presentation of Exceptional ViaCLYR(TM) Clinical Results at Leading Wound Care Symposium
Via ACCESS Newswire
News headline image
BioLargo Subsidiary Clyra Medical Technologies Secures First Stocking Order with Advanced Solution for ViaCLYR(TM) Wound Irrigation Solution
Via ACCESS Newswire
News headline image
BioLargo to Present at Sidoti's Micro-Cap Virtual Conference on Thursday January 22nd at 1pm EST
Via ACCESS Newswire
News headline image
BioLargo Reflects on 2025 Progress and Positions for the Next Phase of Global Infrastructure, Environmental, and Medical Innovation
Via ACCESS Newswire
News headline image
BioLargo Subsidiary BEST Featured in Chemical Engineering Magazine for PFAS Breakthrough
Via ACCESS Newswire
News headline image
BioLargo Reports Q3 2025 Operating and Financial Results
Via ACCESS Newswire
News headline image
BioLargo Q3 2025 Earnings Results Webcast and Conference Call on Friday, November 14th, 2025 - 4:30 PM Eastern Time
Via ACCESS Newswire
News headline image
BioLargo Subsidiary Clyra Medical Technologies Forms Strategic Alliance with Advanced Solution to Launch ViaCLYR(TM) Wound Irrigation Solution Nationwide
Via ACCESS Newswire
News headline image
BioLargo Files Federal Lawsuit Against Pooph Inc.
Via ACCESS Newswire
News headline image
BioLargo Cuts AEC PFAS Treatment Energy Use by >90%, Unlocking Commercial-Scale Water Solutions with Unmatched Total Life Cycle Cost Savings
Via ACCESS Newswire
News headline image
BioLargo Presentation Deck at LD Micro Event Available Online
Via ACCESS Newswire
News headline image
Biolargo Invites You to the Sustain SoCal 16th Annual Energy Event - A Premier Gathering for Clean Energy Innovation
Via ACCESS Newswire
News headline image
BioLargo to Present Its Cellinity Battery Technology at LD Micro Main Event XIX in San Diego on Monday, October 20, at 2:00 p.m. PT
Via ACCESS Newswire
News headline image
BioLargo Subsidiary Clyra Medical Accelerates Toward Near-Term Product Launches and Global Expansion
Via ACCESS Newswire
News headline image
BioLargo Protects Its Intellectual Property That Built a National Brand - Pooph's License Was Revoked for Non-Payment and Unauthorized Activities
Via ACCESS Newswire
News headline image
BioLargo Demonstrates Over 99% Removal of Ultrashort-Chain PFAS Including TFA Using Aqueous Electrostatic Concentration Technology
Via ACCESS Newswire
News headline image
BioLargo to Showcase Breakthrough PFAS Solutions at WEFTEC 2025, Booth #6009
Via ACCESS Newswire
News headline image
BioLargo Protects its Intellectual Property, Revokes Pooph License Due to Failure to Pay and Other Contract Breaches
Via ACCESS Newswire

Frequently Asked Questions

Is Biolargo Inc publicly traded?
Yes, Biolargo Inc is publicly traded.
What exchange does Biolargo Inc trade on?
Biolargo Inc trades on the OTC Traded
What is the ticker symbol for Biolargo Inc?
The ticker symbol for Biolargo Inc is BLGO on the OTC Traded
What is the current price of Biolargo Inc?
The current price of Biolargo Inc is 0.1348
When was Biolargo Inc last traded?
The last trade of Biolargo Inc was at 05/13/26 03:58 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story